UCT, LLC

A solid-phase extraction method utilized to extract 19 synthetic cannabinoids produced recoveries in the range of 85–110% with corresponding RSD values of less than 5%.

A Solid Phase Extraction method utilized to extract 19 synthetic cannabinoids produced recoveries in the range of 85-110% with corresponding RSD values of less than 5%.

This application note outlines the analysis of PFAS in drinking water according to EPA 533 using UCT’s Enviro-Clean® polymeric weak-anion exchange (WAX)SPE cartridges. 

In this application note, a method for extracting a large drugs of abuse panel from urine and plasma using UCT’s Micro-Prep® HLB microelution plate has been described.

Monday, July 19, 2021, 02:00 PM EDT Tuesday, July 20, 2021, 02:00 PM EDT Join us for this free online event to learn about important developments in the analysis of contaminants in a wide range of food and environmental matrices using a range of chromatographic, detection, and sample preparation techniques. A few hours of your time will deliver enormous benefits for your work.

The world of horse race drug testing is constantly evolving. The need for a reliable and quick SPE method for the determination and separation of a wide variety of drug classes is critical to laboratories certified in this realm of veterinary medicine.

This application note exploits the highly retentive but universal nature of UCT’s polymeric Styre Screen® HLD sorbent for the analysis of a wide range of neutral drugs in oral fluid.

This application note outlines a solid-phase extraction (SPE) and LC–MS/MS method for the analysis of 19 synthetic cannabinoids in urine.

UCT offers a simple yet effective procedure to extract and monitor an extensive panel of opioids in blood and urine using solid-phase extraction (SPE) combined with UHPLC–MS/MS.

UCT offers a simple yet effective procedure to extract and monitor an extensive panel of opioids in blood and urine using solid-phase extraction (SPE) combined with UHPLCMS/MS.

This application note describes a simple and robust solid-phase extraction (SPE) procedure for amphetamines in blood, plasma/serum, urine, and tissue samples.

This application note summarizes a validated procedure developed by the US Food and Drug Administration (FDA) for the measurement of 16 PFASs in food using a QuEChERS sample preparation approach.

A quick, easy, effective procedure to identify and quantitate Kratom analytes in blood and urine using Clean Screen® XCEL I SPE cartridges and a Selectra® C18 UHPLC column.

UCT’s polymeric Styre Screen® HLD sorbent analyzes a wide range of neutral drugs in oral fluid.

This application note describes a simple and robust solid-phase extraction (SPE) procedure for amphetamines in blood, plasma, serum, urine, and tissue samples.

This application note outlines a solid-phase extraction (SPE) and LC-MS/MS method for the analysis of 19 synthetic cannabinoids in urine

This application note describes a simple and robust solid-phase extraction (SPE) procedure for Chloroquine, Hydroxychloroquine, and Desethylchloroquine in urine.

This application note outlines a simple 3 step method for the extraction of Loperamide and its main metabolite, N-desmethyl Loperamide, from blood using UCT’s Clean Screen® XCEL I SPE columns.

This application note outlines a simple SPE procedure for the extraction of 26 diverse per- and polyfluoroalkyl substances (PFASs) in drinking water.

This application note describes a simple and rapid solid-phase extraction (SPE) procedure for the analysis of a broad range of acidic, neutral, and basic drugs in oral fluids using UCT's Clean-Screen® XCEL I column.

Presented is a rapid, three step SPE procedure, that includes a concentration step, for the identification and quantification of fentanyl and its urinary analogs.

Outlines a simple three-step method for the extraction of Loperamide and its main metabolite, N-desmethyl Loperamide, from blood using Clean Screen® XCEL SPE|columns.

Presented is a rapid, three step SPE procedure, that includes a concentration step, for the identification and quantification of fentanyl and its urinary analogs.